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protein binding, placental transfer, milk excretion Summary The tissue distribution has been studied in rats of both sexes by whole body autoradiogra phy and by dissection of organs after both a single oral and single intravenous administra tion of radiolabelled salazosulfapyridine (sulfasalazine, SASP). The compound was labelled in two different positions : 14C in the carboxyl group in the salicylic acid part of the molecule and 3H in the sulfonamide part of the molecule making it possible to follow the metabolites after cleavage of the azobridge.
The results of these investigations showed that following oral administration , the drug re mained mainly in the gastro-intestinal tract. At about 8 hours a certain tissue distribution was noticed for both 14C and 3H. The distribution pattern was very different for the two la bellings : the 14C radioactivity was at that time heterogeneously distributed to certain tissues as liver, bone marrow, intestinal mucosa, kidney, lung, connective tissues, ovary, salivary and harderian gland, while the 3H radioactivity was evenly distributed to all tissues includ ing the central nervous system. The radioactivity was almost eliminated from the tissues within 24 hours.
Also after i.v. injection high concentration of radioactivity was found in the gastrointesti nal tract. Already 5 min after administration 25% of the dose was found in the duodenum and 30% in the liver, indicating an extensive biliary excretion. Beside the gastrointestinal tract the highest radioactive concentrations were found in the liver, connective tissues, lung, kidney, and blood. The radioactivity of 14C labelled SASP decreased more rapidly than that of the 3H. The distribution pattern was roughly the same when comparing males and female rats.
In the fetal tissues the 3H radioactivity passed the placental barrier at 4 hours after the injection and was distributed evenly in the fetal tissues , while the 14C radioactivity was only found in the fetal intestines in small amounts.
Trace amounts of excreted radioactivity was found in milk. The milk to plasma ratio for INTRODUCTION Salazosulfapyridine, SASP, a drug known to be effective in inflammatory bowel diseases, has also been reevaluated as an antirheumatic drug with immunomodulating properties.
The knowledge about the tissue distribution in human is limited. The apparent volume of distribution has only been hypothetically calculated as only oral studies have been published. The in vitro binding to human serum proteins is extensive about 99%1). The drug was shown to be present in the synovial fluid in patients with rheumatoid arthritis, although only in some patients the concentration exceeded the plasma concentration of SASP2). According to whole body autoradiography studies on mice, SASP has an affinity for connective tissue 3,4
The present study was designed to evaluate the tissue distribution and excretion of SASP in the rat. The SASP molecule was labelled with 3H and 14C in such a way that the 3H radioactivity corresponded either to intact SASP or sulfapyridine and its metabo lites and the 14C radioactivity corresponded either to intact SASP or 5ASA and its meta bolites. Whole body autoradiography with image analysis was used in combination with, and to select organs for the dissection study in which a more precise quantification of the radioactivity was performed. dried at -20'C for 24 hours, the sections containing 3H where apposed against Ultrofilm 3H (LKB) , a film that is specifically sensitive to the weak radiation of tritium and an X-ray film (Industrex, KODAK) was used to register 14C. The blackening of the films were converted to radioactivity using radio standards (3H Microscales and 14C Microscales,
MATERIALS AND METHODS
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International, UK).
Tissue dissection
At intervals between 5 minutes and 16 hours after the single i.v. dose and between 20 minutes and 96 hours after the single oral dose, blood was collected in heparinized tubes by heart puncture under light ether anaesthesia, the animals were decapitated and tissues were dissected and weighed before storage at 20C until analysed for radioactivity.
Mass balance
The animals (n =5) were after a single intravenous (males) or oral dose (males and females) housed individually in metabolism cages. Prior to the administration, the ani mals were acclimatized in the cages for 24 hours . Urine and faeces were collected at in tervals up to 7 days. The collection vials were protected from light during sampling of urine and faeces. In addition, C02 in expired air was collected during 96 hours from rats given C14C, 3HISASP 500mg/kg body weight p.o. The cages were rinsed with water after completion of the study and the water was analysed regarding radioactive content .
All samples were immediately stored at 201C until analysis . Before storage, methanol (3 times by weight), was added to the faeces samples before homogenization .
Excretion to the milk
After delivery the rats were kept with the pups for 6-12 days before they were placed in metabolic cages. Twenty minutes or 1 hour after i.v. administration and 8 hours after an oral dose of 200mg/kg the lactating rats were given oxytocin (9 IE Syntocinon per kg body weight) to facilitate lactation.
Measurement of radioactivity
The radioactivity of all tissue samples was determined by liquid scintillation counting were estimated.
RESULTS
Protein binding
The protein binding of SASP in vitro in plasma from rat, dog and human was very similar in the different species, 99.7.99.9%, and was independent of the concentration of SASP (Table  I ) . Binding studies with purified human serum albumin in a phosphate buffer gave similar result which confirms that albumin is the major binding protein in plasma.
No binding of SASP to the blood cells was found. In vivo binding studies gave similar result after an i.v. injection of [3HISASP in rat. However, after an oral dose the free fraction of 3H radioactivity increased over time indicating the presence of sulfa pyridine metabolites and that they bind to lesser extent to plasma protein than un changed SASP (Table I ) . Also a small fraction of 3H, probably corresponding to sulfa pyridine metabolites, was bound to blood cells (Table II ) .
Whole body autoradiography after oral administration
The tissue levels of radioactivity from 5 min to 96 hours were very low after oral ad ministration and the radioactivity 14C and 3H remained almost exclusively in the gastro intestinal tract ( Fig. la and d) . However, at 4 and 8 hours a certain radioactivity was registered also in tissues outside the gastrointestinal tract for both labellings. The tissue peak concentrations of the 14C labelling were found at 8 hours. At that time the highest radioactivity was found in the liver and kidney. Relatively high radioactivity was also found in the bone marrow, the intestinal mucosa, the blood, the lung, the connective tissues, the ovary, (not shown) the salivary and the Harderian gland (Fig. 1c ).
The distribution pattern of the 3H labelling was different from that of the 14C pattern at the corresponding time (8 hours) showing a much more even pattern (Fig.  1b) . Thus, at that time most tissues showed about the same concentration including the central ner vous system. Also in body fluids, such as pleural and synovial fluids a certain 3H ra dioactivity was noticed (not shown). However, the highest tissue concentration was obser ved in the connective tissues ( Fig. 1b ).
Tissue dissection after oral administration
The quantitative study on tissue concentrations in male rat confirmed that the major fraction of the oral dose remained in the gastrointestinal tract. During the first hours when the peak plasma level of SASP was expected as well as later when sulfapyridine metabolites appear in plasmas), about 90% of the dose remained in the gastrointestinal tract. Almost 50% of both 14C and 3H remained in the stomach at 4 hours after the administration.
After 24 hours only 5% of the dose was found in the gastrointestinal tract, distributed mainly in the caecum. In other tissues there was a peak concentration of both 14C and 3H after 8 hours , coinciding with the plasma peak concentrations.
Except these peak concentrations high levels of the isotopes compared with the plasma level were also seen, 20 minutes after the oral dose in some animals, with a wide individual variation ( sues (initial data on the male rats are not shown but the distribution was similar as in the female pregnant rats shown in Fig. 2 a. The tissue levels of both 3H and 14C de creased initially rather rapidly with time for most tissues. However, at 4 hours a redistri bution of the 3H labelled substance was obvious, and some tissues as the intestinal mu cosa, the muscles, the myocardium and the brain showed from 20 min to 4 hours a gradually increasing concentration. For the connective tissues, the synovial fluid and the testicles both labellings showed a slow increase during that time. High radioactivity in these tissues is illustrated in Fig. 2b .
Very high radioactivity was noticed from 5 min to 16 hours after the administration in the gastrointestinal tract with both of the labellings. The content of the small intes tines showed high radioactivity from 5 min to 4 hours, while the contents of colon and rectum showed high levels from 4 to 16 hours after administration. The highest concentra tions besides the gastrointestinal tract were found in the liver, the lung and the intes tinal mucosa. The concentration of 14C in the intestinal mucosa was higher than that of the 3H. The uptake in the kidney cortex was consistently higher for the 3H labelling, which roughly followed that of the blood, than that of the 14C labelling. Within the kid ney pelvis and urinary bladder rather high radioactivities were noticed from 5 min to 4 hours for both labellings. However, the excretion of 14C radioactivity into the kidney pelvis was initially high(at 5 min), while the urinary excretion of 3H radioactivity seemed to be more extensive at later times, 1---4 hours.
Tissue dissection after i. v. administration
The tissue concentrations of 14C and 3H in male rats after i.v. administration of C14C, 3HISASP were initially similar and only 3H is presented here (Table  N) . High concentra tions exceeding that of the plasma concentration were found in the liver and duodenum after 5 min indicating a rapid excretion in the bile. About 30% of the dose was found in the liver and about 25% was found in duodenum 5 minutes after injection. After 20 minutes the concentrations of both isotopes were decreased in the liver below the plasma concentration, while the concentration in duodenum increased during that time. After one hour about 55% of the dose was found in the duodenum. The high amount in duodenum was further transported through the intestines during the following 16 hours.
The concentration of 3H and 14C in the kidneys and the lungs, roughly followed the plasma profile but the level was lower. The concentrations in the lungs, thymus, testi cles, skin and knee joint were all low compared with the plasma concentrations.
The ratio 3H/14C in the different tissues showed an increase over time from about 0. 9
after 5 min to about 4 after 4 hours indicating that the SASP molecules were splitted and there was a distribution of sulfapyridine metabolites at that time. The highest ratio was found in the liver, kidneys, stomach and duodenum. However the 3H/14C ratio was below the initial value in caecum, colon and rectum, indicating a higher concentration of am inosalicylic acid (5ASA) metabolites compared to sulfapyridine (SP) metabolites.
Distribution in pregnant rats (autoradiography)
After an i.v. dose of [3H, 14CISASP to pregnant female rats, the tissues were cleared very rapidly as was also seen in the male rats. The radioactivity of the 14C labelled sub stance decreased more rapidly than that of the 3H. The distribution pattern for female rats was similar to that of the male. Thus a high concentration was noticed in the blood by both labellings and the highest tissue concentrations were seen in the liver, the kidney cortex and the intestinal mucosa. Within the connective tissues rather high concentration were noticed from 5 min to 1 hour after the administration for the 14C labelling and from 5 min to 4 hours for the 3H labelling.
No 14C radioactivity was ever observed in fetal tissues, except at 4 hours a certain very low amount, compared to that of the mother, was noticed within the fetal intestinal con tent. For the 3H labelling no radioactivity was noticed in the fetus until at 4 hours (for a comparison see Fig. 2a and c). At that time (Fig. 2 c) the labelled substance passed the placenta barrier, and the distribution pattern of the fetus was equal to that of the mother, which showed a very even distribution of radioactivity . At 16 hours the fetal 3H radioactivity had decreased considerably, and was at that time hardly noticeable .
The placental concentration was always below that of the blood . A rather high uptake was obtained in the yolk sac at 1 hour after administration for both of the labellings. On gestational day 11 no difference in distribution of radioactivity to fetuses was regis tered compared to day 18.
Excretion to the milk
The excretion of SASP to breast milk from the rat was very low . The milk to plasma ratio was 0.13±0.01 for 14C and 0.01±0.01 for 3H 20 minutes after i.v. administration.
After p.o. administration the corresponding ratios were 0.66±0.16 and 0.59--0.03 for 14C and 3H at 8 hours after administration (Table  V) . The concentrations of 14C and 3H were 8.7 and 179pM eq respectively.
Table V Radioactivity in breast milk after administration of C14C, 3HISASP as a single oral dose 200mg/kg or an intravenous dose 5mg/kg in the rat. Ratio between the concentration in breast milk and plasma .
Urinary and faecal excretion
The total mean recovery after different oral doses varied between 69.2 and 92.4% for 3H and between 80 .0 and 89.8% for 14C (Table M) . After an i.v. dose, the total recovery for 3H and 14C was 79.2 and 73.2% respectively.
Most of the radioactivity was recovered to about 20% in males and 17% in female rats. For 3H however, about equal amount of the radioactivity was excreted in urine and faeces in the male rats, while the female rats showed a lower faecal excretion.
The excretion of 14C in expired air was 0.2±0.06% of the given dose (500 mg/kg b.
w.) (not shown). The radioactive content in the female rat carcasses after completion of the sampling of urine and faeces was 0. 1±0.01% 14C and 0.5±0.1% 3H of the administer ed dose.
The recovery of unchanged SASP in urine and faeces ranged as mean value between 0.01 to 2.48% with the higher values in samples from rats given 500mg/kg b.w. (Table111).
DISCUSSION
SASP has been shown to be effective in rheumatoid arthritis8-10~. However, neither the mechanism nor the site of action of the drug is known. Only a small fraction of an oral dose, is systematically available(about 10%). This has been shown in different species ;
the rats), the dog") and man12). There are several similarities in the pharmacokinetic be haviour of SASP in the rat compared with man. Although the rat has a much more rapid clearance, the absorption is similar and also the metabolism5,13
The extensive binding to serum proteins seen in human (99%) 1) was in this study also found in the rat and the dog. There was no binding to the blood cells. Sulfapyridine is present at higher concentrations in plasma after an oral dose compared with SASP, and it binds to a less er extent to plasma proteins. According to Fischer and Klotzl4) the in vitro binding of sulfapyridine was about 50% and for acetylsulfapyridine about 74%. Similar result was also obtained in vivo in the rat in this study, as after an oral dose of C3HISASP, the bound radioactivity decreased over time when sulfapyridine metabolites have been shown to appear in the plasma 5). A small fraction of the radioactivity was also bound to the blood cells.
The low bioavailability, a small apparent volume of distributions) and the extensive protein binding indicate that the tissue concentrations of SASP can be expected to be low. This was also confirmed in this study. After an i.v. injection of radioactively label led SASP, the tissue concentration of radioactivity, was low compared to the plasma levels throughout the period studied.
However, the high degree of plasma protein binding of SASP did not prevent a rapid hepatic clearance of SASP. Five minutes after the i.v. injection more than 50% of the dose was found in the liver and duodenum, indicating both a rapid liver uptake and biliary excretion of intact substance. The tissue distribution pattern obtained after the intrave nous injection was in close agreement with previous autoradiographic investigations in mice','). The distribution pattern of 14C and 3H labelled SASP was very similar up to 4 hours. However, it is possible that part of the radioactivity also early after administra tion may be represented by metabolites of unsplitted SASP. In the previous study') a con siderably slower elimination of the radioactivity in plasma was obtained compared to that of intact SASP. In the connective tissues, the radioactivity was successively increased to concentrations similar to that in liver and plasma.
Beside the extensive hepato-biliary excretion and an urinary excretion there was a transport through the gastrointestinal wall. This has been shown earlier in mice, by having the common bile duct ligated3).
The distribution of tritium in pregnant rats and fetuses was equal to that obtained after injection of 35S-labelled sulfapyridine 3) showing that no SASP penetrates through the placenta. Sulfapyridine or sulfapyridine metabolites were transferred and distributed in the fetus as in the mother. However, negligible amounts of 14C-radioactivity was de tected in the autoradiographic study, indicating 5-aminosalicylic acid and/or metabolites in the fetal intestine.
After an oral administration of radiolabelled SASP in rat it was shown in the previous papery that mainly sulfapyridine was systemically available, having a plasma peak after 8 hours. 5-aminosalicylic acid was also absorbed to some extent , with a plasma peak after about 8 hours. The major part of the radioactivity was however found in the gastro intestinal tract.
The tissue concentrations of radioactivity followed the plasma profile with maximal levels about 8 hours after the administration. Due to the reductive cleavage of SASP to different metabolites, the 14C and 3H autoradiograms gave rise to quite dif ferent distribution patterns. The characteristics of the 14C pattern, corresponding to met abolites of 5-aminosalicylic acid, were high radioactivity in liver , kidney, connective tissues, blood, bone marrow and ovary. A similar distribution picture has earlier been obtained after i.v. injection of 14C labelled 5-amino-salicylic acid 3).The distribution pattern also showed some similarities with 14C salicylic acid and 14C acetylsalicylic acidly, e. g.
the concentration in synovial fluids and in connective tissues. The 3H pattern, correspond ing to sulfapyridine metabolites, was characterised by an evenly distributed radioactivity.
A certain distribution was noticed in connective tissues which is in contrast to what has earlier been noted after an i.v. injection of 35S-labelled sulfapyridine , where no binding to connective tissues was found'). This may indicate a slow uptake of SASP into the con nective tissues (at 8 hours) after the oral dose.
Unchanged SASP is mainly excreted via the urine in the man and nothing was detec table in faeces"). In the rat however the main part, more than 90% of the excreted SASP was found in faeces after an oral dose correlating well to the high biliary excretion seen in the rat. The amount of SASP excreted in faeces varied between 0.12.2.48% of the dose.
Sulfapyridine metabolites were found in the faeces to a higher extent in the rat than what has been found in human beings. The urinary excretion of sulfapyridine metabo lites in man is 60-80%16) while in the rat it was 40-50% and equal amounts in the fae ces. However, the faecal excretion was found to be lower in female rats than in male rats depending on sex differences in the metabolisms, 13) It is conceivable that the differ ences between male and female rats were due to a less effective biliary excretion possi bly caused by the lower hydroxylation and conjugation rate of SP observed in the female rats.
In conclusion, due to a low bioavailability, low volume of distribution and high biliary excretion, the major part of the dose remains in the gastrointestinal tract after an oral as well as an intravenous dose of SASP. Thus , the tissue concentrations were low, par ticularly for 14C reflecting the 5ASA metabolites . Higher and more evenly distributed levels were obtained with 3H corresponding to sulfapyridine metabolites .
